Sioxon-S 250mg/125mg Injection
Marketer
savoy Biotech
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Sioxon-S 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical practitioner. Consistent adherence to the prescribed regimen is crucial; premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions warrant immediate medical attention. Allergic responses (rash, pruritus, edema, dyspnea) necessitate prompt medical help. Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if experiencing somnolence or dizziness. Sufficient rest, balanced nutrition, and hydration are recommended for optimal recovery. Laboratory monitoring may be employed to assess therapeutic response.
Primary Ingredients of Sioxon-S 250mg/125mg Injection
There is no text provided to rephrase.
Uses of Sioxon-S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Sioxon-S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Sioxon-S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Sioxon-S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Sioxon-S 250mg/125mg Injection works:
The injectable drug Sioxon-S (250mg/125mg) unites Ceftriaxone, a bacterial growth inhibitor, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial survival. Sulbactam augments Ceftriaxone's effectiveness by counteracting bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Sioxon-S 250mg/125mg Injection does not produce adverse reactions when taken with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Sioxon-S, 250mg/125mg, is typically deemed safe for use in pregnancy. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
Administering Sioxon-S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Sioxon-S 250mg/125mg Injection could potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Sioxon-S 250mg/125mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable medication Sioxon-S 250mg/125mg requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Sioxon-S 250mg/125mg Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Sioxon-S 250mg/125mg Injection :
Omitting a scheduled Sioxon-S 250mg/125mg Injection requires immediate physician consultation.
Facts to Know About Sioxon-S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently